Double-blind randomized controlled trial will enroll up to 225 children at UCLA and Seattle Children’s Hospital NeuroSigma will provide...

NeuroSigma Announces King’s College London Team Receives MHRA Approval to Commence Largest Clinical Trial of eTNS for Pediatric ADHD to...

March 7, 2022 - Boston, MA - The RepTrak Company, the world’s leading reputation data and insights company, today announced the...